George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

Share Price Information for FD Technologies (FDP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,224.00
Bid: 1,220.00
Ask: 1,224.00
Change: -6.00 (-0.49%)
Spread: 4.00 (0.328%)
Open: 1,200.00
High: 1,232.00
Low: 1,200.00
Prev. Close: 1,230.00
FDP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

3 Mar 2015 11:06

RNS Number : 3933G
First Derivatives PLC
03 March 2015
 

3 March 2015

 

First Derivatives PLC

("FD" or the "Company")

 

Result of General Meeting

Application for admission of new ordinary shares

 

FD (AIM:FDP.L, ESM:FDP.I), a leading provider of software and consulting services, announced on 12 February 2015 that the Company had placed 200,003 new ordinary shares (the "Placing Shares") conditional upon approval by shareholders at a General Meeting which was held earlier today.

 

The Company is pleased to confirm that the resolution proposed at the General Meeting was duly passed without amendment. As a result, the Placing Shares will be issued, allotted and admitted to trading on AIM and the ESM on 4 March 2015.

 

In addition, further to the announcement on 26 February 2015, FD confirms that the acquisition of Prelytix LLC was completed and that the Company has now issued and allotted 74,572 new ordinary shares (the "Consideration Shares") in respect of the initial consideration.

 

Application has been made for the Consideration Shares to be admitted to trading on AIM and the ESM and it is expected that admission will also take place on 4 March 2015. 

 

The Placing Shares and the Consideration Shares will rank pari passu with the Company's existing ordinary shares.

 

The current total issued share capital of the Company is 22,702,201 ordinary shares. Following admission of the Placing Shares and the Consideration Shares the total issued share capital of the Company will increase to 22,976,776 ordinary shares. This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a charge to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules. The Company does not hold any shares in treasury and therefore the total number of voting rights in the Company will be 22,976,776.

 

 

Enquiries:

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Finance Director

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

Charles Stanley Securities

(Nominated Adviser and Broker)

Russell Cook

Carl Holmes

+44 (0)20 7149 6000

Goodbody

(ESM Adviser and Broker)

Linda Hickey

Finbarr Griffin

+353 1 667 0420

Walbrook PR

Financial PR

Sam Allen

+44 (0)20 7933 8780

 

 

About First Derivatives

FD is a global technology provider with nearly 20 years of experience of working with some of the world's largest finance, technology and energy institutions. It holds a 65% stake in Palo Alto-based Kx Systems, developer of the world-leading database technology, kdb+. It employs over 1,200 people worldwide and has operations in London, New York, Stockholm, Singapore, Hong Kong, Sydney, Toronto, Philadelphia, Dublin and its headquarters in Newry.

For further information please visit www.firstderivatives.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROMPKNDKDBKDPNK
Date   Source Headline
23rd Apr 20247:00 amRNSNotice of Results
22nd Apr 20244:11 pmRNSHolding(s) in Company
22nd Apr 20247:00 amRNSHolding(s) in Company
15th Apr 20246:14 pmRNSIssue of Equity
8th Apr 20244:53 pmRNSHolding(s) in Company
4th Apr 20244:53 pmRNSHolding(s) in Company
4th Apr 20244:14 pmRNSHolding(s) in Company
2nd Apr 20243:43 pmRNSHolding(s) in Company
2nd Apr 20243:26 pmRNSHolding(s) in Company
2nd Apr 20248:39 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSHolding(s) in Company
28th Mar 20243:24 pmRNSHolding(s) in Company
19th Mar 20244:35 pmRNSIssue of Equity
18th Mar 20244:22 pmRNSHolding(s) in Company
15th Mar 20246:23 pmRNSHolding(s) in Company
15th Mar 20245:27 pmRNSCorrection - Holding(s) in Company
15th Mar 20245:20 pmRNSHolding(s) in Company
15th Mar 20244:43 pmRNSHolding(s) in Company
13th Mar 20245:15 pmRNSHolding(s) in Company
13th Mar 20244:34 pmRNSHolding(s) in Company
13th Mar 202410:45 amRNSHolding(s) in Company
11th Mar 202412:15 pmRNSHolding(s) in Company
11th Mar 202411:47 amRNSDirector/PDMR Shareholding
7th Mar 202410:57 amRNSHolding(s) in Company
6th Mar 20244:50 pmRNSHolding(s) in Company
6th Mar 20247:00 amRNSHolding(s) in Company
4th Mar 20247:00 amRNSHolding(s) in Company
1st Mar 20247:00 amRNSConclusion of Structure Review
1st Mar 20247:00 amRNSFY24 Trading Update
15th Jan 20245:43 pmRNSHolding(s) in Company
19th Dec 20235:27 pmRNSCorrection: Holding(s) in Company
18th Dec 20237:00 amRNSHolding(s) in Company
15th Dec 20237:00 amRNSDirectorate Change
29th Nov 20237:00 amRNSKX hosts Investor Event: Winning in the AI Era
28th Nov 20237:00 amRNSLaunch of KDB.AI Server
22nd Nov 20231:54 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSDirector/PDMR Shareholding
14th Nov 20238:57 amRNSDirector/PDMR Shareholding
13th Nov 20233:04 pmRNSHolding(s) in Company
6th Nov 20237:00 amRNSNotice of KX Investor Event
24th Oct 20237:00 amRNSResults for the six months ended 31 August 2023
2nd Oct 20237:00 amRNSNotice of Results
31st Aug 20239:18 amRNSTotal Voting Rights
15th Aug 20237:00 amRNSIssue of Equity
31st Jul 20231:59 pmRNSTotal Voting Rights
20th Jul 20233:30 pmRNSResult of AGM
28th Jun 20234:17 pmRNSPDMR Notice and Issue of Equity
27th Jun 20234:30 pmRNSNotice of AGM
5th Jun 202312:43 pmRNSHolding(s) in Company
30th May 20231:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.